Stock Explodes 260% After FDA Grants Key Cancer Drug Designation

Why is Trump imposing 50% tariffs on copper imports? How are Trump’s tariffs impacting U.S. retail sales? Why is Apple’s COO retiring this year? What caused the recent flood crisis in Texas? How is Amazon handling Prime Day amid tariffs? Why did Tesla shares drop after Musk’s political party news? What’s behind Samsung’s expected profit slump?

Stock Explodes 260% After FDA Grants Key Cancer Drug Designation

benzinga.com/trading-ideas/movers/25/07/46280070/mustang-bio-mbio-stock-explodes-260-after-fda-grants-key-cancer-drug-designation

Mustang Bio Inc (NASDAQ:MBIO) shares are trading sharply higher Monday afternoon. The company earlier saw a positive development as the FDA granted Orphan Drug Designation to its cell therapy candidate, MB-101. Here’s what investors need to know.
What To Know: This designation is for the…

This story appeared on benzinga.com, 2025-07-07 16:47:13.